Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update for dalantercept in squamous cell carcinoma of the head and neck has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 study comparing two treatments in patients with recurrent or metastatic squamous cell carcinoma of the head and neck has completed…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
This post-marketing surveillance trial evaluating cetuximab plus radiotherapy in unresectable locally advanced head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract [Phase 2, Phase 3]
A completed Phase 2/3 trial comparing two re-irradiation protocols for squamous cell carcinoma of the head and neck in patients previously i…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 clinical trial evaluating Bevacizumab/Tarceva and Tarceva/Sulindac in squamous cell carcinoma of the head and neck was terminated,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: CTC Detection Rate in SCCHN With a in Vivo Device [NA]
The update describes a trial evaluating circulating tumor cell detection in squamous cell carcinoma of the head and neck using an in vivo de…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck [Phase 1]
A Phase 1 study evaluating the addition of panitumumab to chemoradiotherapy for squamous cell carcinoma of the head and neck has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1]
Phase 1 study evaluating azacitidine in combination with cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck;…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) [Phase 3]
Phase 3 trial comparing nivolumab to investigator's choice therapy in recurrent/metastatic squamous cell carcinoma of the head and neck comp…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck [Phase 1, Phase 2]
Phase 1/2 trial evaluating Abraxane with carboplatin, cetuximab (Erbitux) and IMRT for locally advanced squamous cell carcinoma of the head …
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study [Phase 2]
Phase 2 study of docetaxel/cisplatin/5-fluorouracil for HPV-positive head and neck squamous cell carcinoma was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy
A post-marketing surveillance study of docetaxel-based chemotherapy in non-small cell lung cancer and head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck [Phase 2]
Phase 2 trial evaluating adjuvant cetuximab with chemoradiotherapy using either cisplatin or docetaxel in resected stage III/IV head and nec…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck [Phase 2]
A Phase 2 trial comparing MEHD7945A versus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck h…
-
FDA approval · 2016-10-11FDA Approved: ERBITUX — Supplemental Application (ImClone LLC)
The FDA approves a supplemental application for Erbitux (cetuximab) filed by ImClone LLC.
-
CLINICAL_TRIALS withdrawal · 2016-08-08Clinical Trial Update: A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT) [Phase 2]
A Phase II study evaluating low-dose fractionated radiotherapy for squamous cell carcinoma of the head and neck has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of talactoferrin in patients with relapsed or refractory non-small cell lung cancer or…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy [Phase 2]
Phase 2 clinical trial comparing concurrent chemoradiotherapy to cetuximab with radiotherapy after neoadjuvant chemotherapy in locally advan…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 study of BIND-014 across urothelial carcinoma, cholangiocarcinoma, cervical cancer, and squamous cell carcinoma of the head and ne…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) [Phase 2]
Phase 2 trial update for PRISM evaluating panitumumab as second-line monotherapy in head and neck cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT) [Phase 2]
Phase 2 clinical trial update for squamous cell carcinoma of the head and neck focusing on surgery and radiotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy [Phase 2]
Phase 2 trial update for Sym004 in squamous cell carcinoma of the head and neck after anti-EGFR therapy failure.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer [Phase 2]
Phase 2 study of Proxinium for squamous cell carcinoma of the head and neck was terminated. This update confirms the trial status as TERMINA…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck [Phase 3]
This clinical trial update reports a Phase 3 study of E10A for squamous cell carcinoma of the head and neck, sponsored by Guangzhou Double B…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors [Phase 1]
Phase 1 safety study of recombinant vaccinia virus JX-594 for refractory solid tumors completed, evaluating melanoma, lung cancer, renal cel…